|
Match
|
Document |
Document Title |
|
|
US20120009133 |
POLY (NON-CONJUGATED DIENE) BASED SUNSCREENS
A poly(non-conjugated diene) based sunscreen has a plurality of repeating units where each repeating unit has at least one UV absorbing chromophore that is situated between and connected by chains... |
|
|
US20130096322 |
METHOD OF BIOBASED CHEMICAL PRODUCTION FROM CRUDE BIOGLYCERIN OF RECYCLED OIL, GREASE, AND FAT ORIGIN
A method of production of value-added, biobased chemicals, derivative products, and/or purified glycerin from bioglycerin of recycled oil, grease, and/or fat origin is described herein. A method... |
|
|
US20120220655 |
CRYSTALLINE FORMS OF FESOTERODINE FUMARATE AND FESOTERODINE BASE
Polymorphically pure crystalline forms of fesoterodine fumarate and fesoterodine base are described and characterized. |
|
|
US20120282200 |
UV ABSORBING DENTRITIC POLYETHER PREPARED BY POLYMERIZATION OF OXETANES
The present invention relates to a polymer comprising a hyperbranched dendritic polyether backbone covalently bonded via an oxygen bridge to at least one UV absorbing chromophore characterized in... |
|
|
US20110020424 |
USE OF THE IRRITATING PRINCIPAL OLEOCANTHAL IN OLIVE OIL, AS WELL AS STRUCTURALLY AND FUNCTIONALLY SIMILAR COMPOUNDS
The invention provides oleocanthal analogs and methods of using oleocanthals in various formulations including, food additives; pharmaceuticals; cosmetics; animal repellants; and discovery tools... |
|
|
US20130142834 |
LOCAL DELIVERY OF DRUGS FROM SELF ASSEMBLED COATINGS
The invention relates to oligofluorinated coatings and their use in drag delivery The oligofluorinated coatings are compositions comprising formula (XVII). These coatings are used in a method of... |
|
|
US20120219538 |
STABILIZED PROTEIN FORMULATIONS AND USE THEREOF
The present invention is directed to stable protein formulations, related methods and uses thereof. In particular, the invention relates to a method of stabilizing therapeutic proteins in aqueous... |
|
|
US20130072559 |
RETINAL DERIVATIVES AND METHODS FOR THE USE THEREOF FOR THE TREATMENT OF VISUAL DISORDERS
Compositions of and methods for using synthetic retinal derivatives as retinoid replacements and opsin agonists are provided. |
|
|
US20150111966 |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF FIBROMYALGIA PAIN
The invention relates to the compounds of formula I or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical... |
|
|
US20110086818 |
METHODS, COMPOSITIONS, AND KITS FOR TREATING PAIN AND PRURITUS
The invention features methods, compositions, and kits for selective inhibition of pain-and itch sensing neurons (nociceptors and pruriceptors) by drug molecules of small molecule weight, while... |
|
|
US20150190336 |
FILAGGRIN GENE EXPRESSION PROMOTER
The present invention provides a novel substance that promotes expression of filaggrin gene involved in improvement of the moisture retention function of skin. The inventors of the present... |
|
|
US20110301288 |
THIOIC ACIDS AS BUILDING BLOCK FOR POLYTHIOESTERS
The present invention relates to thioic acids according to formula (II) suitable as building block for polythioesters; Wherein X is O, N or S and whereby R1 is chosen from (—CH2—)2, —CH2—O—CH2— or... |
|
|
US20130184487 |
Method to produce a stable dry ionic-bonded creatine alpha ketoglutarate of high oral absorbability
The invention provides a method to produce a stable, ionic-bonded, dry creatine-α-ketoglutarate product at a molar ratio of about 2:1. The product is stable at room temperature when kept dry for... |
|
|
US20080188556 |
Water-Soluble Prodrugs of Florfenicol and its Analogs
The present invention discloses certain novel prodrugs of florfenicol and/or of florfenicol analogs, including prodrugs of salts pharmaceutically acceptable salts of florfenicol and its analogs,... |
|
|
US20150141479 |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF MODERATE TO SEVERE PAIN
The invention relates to the compounds of formula I and formula II or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The... |
|
|
US20150238414 |
Misoprostol Formulation
A method of reducing the likelihood of infection requiring use of antibiotics during or after induction of labour in a female, comprises administering intravaginally to the female an insert... |
|
|
US20080139831 |
Water Tolerant Emulsion Stabilizers
An emulsion stabilizer is disclosed having a water tolerance value of between more than about 1.0 and equal or less than about 11.0. |
|
|
US20140179723 |
LOCAL COCHLEAR APPLICATION OF STATINS FOR STIMULATING NEURITE REGROWTH IN THE COCHLEA
Statin compositions are disclosed for stimulating neurite growth from spiral ganglion neurons in the inner ear and methods for preventing damage to or treating damage of auditory neurons and/or... |
|
|
US20140364604 |
METHOD OF MAKING MONOMETHYL FUMARATE
Methods of making monomethyl fumarate, which can then also be used in methods of making prodrugs of monomethyl fumarate, are disclosed. Monomethyl fumarate and prodrugs of monomethyl fumarate are... |
|
|
US20110110914 |
METHODS FOR TREATMENT OF ONCOLOGICAL DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS
Methods and formulations for treating oncological disorders in humans using epimetabolic shifters, multidimensional intracellular molecules or environmental influencers are described. |
|
|
US20120178704 |
PREVENTION AND TREATMENT OF COLON CANCER
Stilbene compounds for the prevention and treatment of colon cancer or colon inflammation and methods of using same are provided. |
|
|
US20110147986 |
Oxygen Resistant Organic Peroxides for Reticulation/Cure and Their Use in the Process of Continuous Vulcanization in Hot Air Tunnel
This application refers to Organic Peroxides of the Dialcyl, Perester, Perketal, and Dialkyl classes, which were modified to resist to oxygen, destined to be used in the process of production of... |
|
|
US20150133408 |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF RESTLESS LEG SYNDROME AND FIBROMYALGIA
The invention relates to the compounds of formula I or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical... |
|
|
US20120148690 |
SKIN BARRIER FUNCTION RECOVERY ACCELERATOR
A novel skin barrier function recovery acceleration method and accelerator are provided. The present invention provides a skin barrier function recovery accelerator that comprises a TRPA1 agonist... |
|
|
US20100307378 |
CARBAMATE-METHACRYLATE MONOMERS AND THEIR USE IN DENTAL APPLICATIONS
The present invention relates, generally, to monomers containing carbamate-methacrylates or derivatives of carbamate-methacrylates, processes for making the monomers, and compositions comprising... |
|
|
US20120108844 |
METHOD OF MEASURING ENTRY OF WATER INTO PHOSGENE-CONDUCTING PLANTS
The invention relates to a method of measuring entry of water and resulting corrosion in plants for producing isocyanates by reacting phosgene with one or more primary amines in a solvent. The... |
|
|
US20100092420 |
Preservative Systems Comprising Cationic Surfactants
Preservative systems on the basis of cationic surfactants are known i n the art, a typical example of such cationic surfactants is the ethyl ester of the lauramide of arginine monohydrochloride... |
|
|
US20110319516 |
RELEASE AGENT PARTITION CONTROL IN IMPRINT LITHOGRAPHY
Release agents with increased affinity toward nano-imprint lithography template surfaces interact strongly with the template during separation of the template from the solidified resist in a... |
|
|
US20110020251 |
Ultraviolet-Absorbing Compounds
Disclosed are novel ultraviolet-absorbing compounds produced by two embodiments. By a first embodiment, the ultraviolet-absorbing compound is derived from at a first reactant being a UV absorber... |
|
|
US20120156255 |
DRUG ELUTING PATCH FOR THE TREATMENT OF LOCALIZED TISSUE DISEASE OR DEFECT
A polymeric matrix for delivery of an HMG CoA reductase inhibitor such as a statin to tissue such as cardiac tissue in need thereof for the treatment or prevention of a disease or defect such as... |
|
|
US20130338089 |
METHODS AND COMPOUNDS FOR MODULATING THE SECRETION OR EXPRESSION OF ADHESION PROTEINS OR ANGIOPOIETINS OF CELLS
This invention provides methods, processes, compounds and compositions for modulating the gene expression or secretion of adhesion proteins, angiopoietins or their receptors to cure diseases, for... |
|
|
US20120252892 |
METHODS FOR TREATING FIBROMYALGIA SYNDROME
The invention is directed to a method of treating fibromyalgia syndrome in a subject, comprising administering a therapeutically effective amount of a carbamoyl compound, or pharmaceutically... |
|
|
US20140243411 |
TOPICAL DTPA PRODRUG FORMULATIONS AND METHODS OF USING THE SAME
The present invention relates to topical trisodium diethylenetriamine pentaacetic acid (DTPA) prodrug formulations and methods of using the same. |
|
|
US20120101087 |
Generation of Combinatorial Synthetic Libraries and Screening for Novel Proadhesins and Nonadhesins
The present invention relates to, in part, novel bisphenol compounds useful for the recognition, attachment and growth of unwanted biologics on natural and manmade surfaces. Another aspect of the... |
|
|
US20130078291 |
BIO-ADHESIVE AGENT COMPRISING SURFACE-MODIFIED HYDROXYAPATITE AND USE THEREOF
The present invention relates to a bio-adhesive agent comprising a surface-modified hydroxyapatite and its use. More specifically, the present invention relates to a bio-adhesive agent for the... |
|
|
US20110190251 |
METHOD FOR INHIBITING THE BUILD-UP OF ARTERIAL PLAQUE BY ADMINISTERING FULLERENES
Disclosed herein are methods of inhibiting the build-up of arterial plaque in a subject in need thereof. These methods comprise administering to the subject in need thereof a therapeutically... |
|
|
US20120000603 |
ADHESIVE
The invention relates to the use of special isocyanate-terminated polyurethane prepolymers in adhesive formulations. Said adhesive formulations can be used in applications wherein a direct or... |
|
|
US20110105608 |
MODULATORS OF NUCLEAR RECEPTOR CO-REGULATORY PROTEIN BINDING
Disclosed are novel compounds and compositions for inhibition of androgen and estrogen receptor signaling, methods for inhibiting androgen signaling, methods for inhibiting estrogen signaling,... |
|
|
US20150073131 |
METHOD FOR PRODUCING BIOBASED CHEMICALS FROM PLANT LIGNIN
The present invention is directed generally to a method of production of value-added, biobased chemicals from lignin sources, including waste lignin. A method of producing biobased aromatic... |
|
|
US20130261133 |
Therapeutic Compounds for Protozoal and Microbial Infections and Cancer
The compounds of the invention exhibit antiprotozoal, antimicrobial, and anticancer properties that are useful for the treatment or prevention of infections or cancer in a patient (e.g., a human).... |
|
|
US20110091404 |
COMPOSITIONS COMPRISING FRAGRANCE SUBSTANCES AND COMPRISING CETYL NONANOATE AND/OR STEARYL NONANOATE
The invention relates to the use of n-hexadecyl n-nonanoate (CAS number 72934-15-7, hereafter cetyl nonanoate) and n-octadecyl n-nonanoate (CAS number 107647-13-2, hereafter stearyl nonanoate) and... |
|
|
US20140296241 |
THE USE OF (2R, 6R)-HYDROXYNORKETAMINE, (S)-DEHYDRONORKETAMINE AND OTHER STEREOISOMERIC DEHYDRO AND HYDROXYLATED METABOLITES OF (R,S)- KETAMINE IN THE TREATMENT OF DEPRESSION AND NEUROPATHIC PAIN
The disclosure provides pharmaceutical preparations containing (2R,6R)-hydroxynorketamine, or (R)- or (S)-dehydronorketamine, or other stereoisomeric dehydro or hydroxylated ketamine metabolite.... |
|
|
US20150247281 |
REDUCED MEDICAL WET PACKS, POST STEAM STERILIZATION
The present disclosure describes a surfactant treatment for a polyolefinic nonwoven fabric used to wrap items to be sterilized. The surfactant treatment consists essentially of carbon, hydrogen... |
|
|
US20140242606 |
PROBE FOR iFRET AND USE THEREOF
The present invention relates to a probe for iFRET and use thereof. Specifically, the present invention relates to a novel probe for iFRET, a method for preparing the probe for iFRET, a method for... |
|
|
US20140188227 |
Fibrous Scaffold for Use in Soft Tissue Engineering
The present invention relates to a fibrous scaffold for use as a substrate in soft tissue applications, in particular for preparing annulus fibrosus (AF) tissue. In aspects, the present invention... |
|
|
US20140322810 |
NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES
This invention provides a method of synthesizing new active compounds for pharmaceutical uses including cancer treatment, wherein the cancers comprise breast, leukocytic, liver, ovarian, bladder,... |
|
|
US20140199378 |
NEW NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES
This invention provides a method of synthesizing new active compounds for pharmaceutical uses including cancer treatment, wherein the cancers comprise breast, leukocytic, liver, ovarian, bladder,... |
|
|
US20110269689 |
HIGH PENETRATION COMPOSITIONS AND THEIR APPLICATIONS
High penetration compositions (HPC) of a parent compound, which are capable of crossing biological barriers with high penetration efficiency. The HPCs are capable of being converted to parent... |
|
|
US20120088782 |
LPA RECEPTOR ANTAGONIST
A compound of the general formula (I): (wherein the symbols are as defined in the description), or a non-toxic salt thereof. This compound engages in LPA receptor bonding and antagonism and hence... |
|
|
US20120142958 |
CHEMICAL RECYCLING OF PLA BY HYDROLYSIS
A process for recycling a polymer blend necessarily containing PLA, comprising grinding, compacting, dissolving in a solvent of PLA, removing the undissolved contamining polymers, alcoholysis... |